Meta-analysis of Hyperhomocysteinemia as a Risk Factor for Venous Thromboembolic Disease
Archives of Internal MedicinePublished 26 October 1998
Joel G. Ray
Citations317
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A significant risk for VTE in the presence of hyper-Hcy apparently exists among a spectrum of patients with first or recurrent venous thromboembolic events, and appears to be most significant for patients with VTE disease before age 60 years.
Abstract
A significant risk for VTE in the presence of hyper-Hcy apparently exists among a spectrum of patients with first or recurrent venous thromboembolic events. This risk appears to be most significant for patients with VTE disease before age 60 years. A well-designed prospective study is needed to confirm these findings.
Keywords
Medicine
Controlled Clinical TrialsMeta-analysis in clinical trials
39,316 Citations1986Rebecca DerSimonian, Nan M. Laird
This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.
JAMAA Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
3,594 Citations1995Carol J. Boushey
Higher folic acid intake by reducing tHcy levels promises to prevent arteriosclerotic vascular disease and under different assumptions, 13,500 to 50,000 CAD deaths annually could be avoided.
Food and Chemical ToxicologyStatistical methods in cancer research. Vol. 1. The analysis of case-control studies
1,725 Citations1983
New England Journal of MedicineHyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
1,052 Citations1996Martin den Heijer, Ted Koster +6 more
High plasma homocysteine levels are a risk factor for deep-vein thrombosis in the general population and was stronger among women than among men and increased with age.
Medical Entomology and ZoologyMeta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine
876 Citations1994Diana B. Petitti
JAMAA quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
770 Citations1995Carol J. Boushey
American Journal of Clinical NutritionVitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
469 Citations1993JB Ubbink, WJ Vermaak +2 more
Because hyperhomocysteinemia is implicated as a risk factor for premature occlusive vascular disease, appropriate vitamin therapy may be both efficient and cost-effective to control elevated plasma homocysteine concentrations.
CirculationHyperhomocysteinemia and Low Pyridoxal Phosphate
395 Citations1995Killian Robinson, Ellen Mayer +11 more
Within the range currently considered to be normal, the risk for coronary disease rises with increasing plasma homocysteine regardless of age and sex, with no threshold effect.
The LancetIs hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
371 Citations1995Martin den Heijer, W.B.J. Gerrits +5 more
Hyperhomocysteinaemia is a common risk factor for recurrent venous thrombosis and can lead to a two-fold or three-fold increase in risk.
Journal of NutritionVitamin Requirements for the Treatment of Hyperhomocysteinemia in Humans
369 Citations1994Job Ubbink, WJ Vermaak +4 more
F folate deficiency may be an important cause of hyperhomocysteinemia in the general population, and a modest vitamin supplement containing folic acid, Vitamin B-12 and vitamin B-6 is effective in reducing elevated plasma homocysteine concentrations.
CirculationInterrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism
343 Citations1997Paul M. Ridker, Charles H. Hennekens +4 more
It is shown that hyperhomocysteinemia is a risk factor for venous thromboembolism (VTE) only when it coexists with factor V Leiden, which is responsible for most cases of resistance to activated protein C.
Arteriosclerosis and Thrombosis A Journal of Vascular BiologyHigh prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
253 Citations1994C Falcón, Marco Cattaneo +3 more
It is indicated that moderate hyperhomocyst(e)inemia is associated with an increased risk of developing venous thromboembolism at a young age and that measurements of fasting and postmethionine plasma homocyst (e)ine levels may be useful in the evaluation of patients with juvenile venous Thrombosis, particularly if their family history suggests the presence of an inherited abnormality.
Annals of Internal MedicinePrevalence of Moderate Hyperhomocysteinemia in Patients with Early-Onset Venous and Arterial Occlusive Disease
232 Citations1995Isabella Fermo, Silvana Vigano' D'Angelo +4 more
The aim of this study was to evaluate the prevalence of moderate hyperhomocysteinemia and of established disorders of inherited thrombophilia in a series of consecutive patients with early-onset venous or arterial occlusive disease.
CirculationThermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease.
228 Citations1993Seok Seon Kang, Edward Passen +3 more
BloodThe clinical spectrum of heterozygous protein C deficiency in a large New England kindred
203 Citations1989EG Bovill, KA Bauer +3 more
The absence of thromboembolic manifestations in many of the protein-C deficient family members to date indicates that other, as yet undefined, factors must play an important role in the clinical expression of this disorder.
Annals of Internal MedicineThrombosis in Antithrombin-III-deficient Persons
176 Citations1992Christine Demers, Jeffrey S. Ginsberg +3 more
Based on the data from this antithrombin-III-deficient kindred, lifelong anticoagulant prophylaxis does not appear to be warranted in asymptomatic carriers, and proprylaxis could be limited to periods of high risk for thrombosis.
CirculationThermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease.
140 Citations1993S SKang, E LPassen +3 more
Thrombosis and HaemostasisHyperhomocysteinemia and Deep-Vein Thrombosis A Case-Control Study
129 Citations1996Paolo Simioni, Paolo Prandoni +6 more
Clinical BiochemistryMeasurement of homocyst(e)ine in the prediction of arteriosclerosis
126 Citations1995Louis-Jacques Fortin, Jacques Genest
The strength of this association appears to be stronger for peripheral and cerebrovascular disease than for CAD, and H(e) levels are independent of the conventional cardiovascular risk factors (age, gender, lipid and lipoprotein cholesterol levels, hypertension, or cigarette smoking).
Journal of Epidemiology & Community HealthThe potential and limitations of meta-analysis.
121 Citations1991Tim D. Spector, Simon G. Thompson
The differing applications and limitations of meta analysis are discussed, with a review of the analytic methods used and the problems and biases encountered.
Thrombosis ResearchElevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters
101 Citations1993T. Bienvenu, Annick Ankri +3 more
Vitamin therapy, already used in homozygote homocystinuric patients, might be beneficial in the prevention of thromboembolic disease in heterozygous patients, especially knowing that HCy presents a direct cytotoxic effect.
HaemostasisPlasma Homocysteine in Venous Thromboembolism
98 Citations2009Lars Brattström, Lilian Tengborn +3 more
No significant differences in the plasma homocysteine concentrations, either in the fasting state or after methionine loading, are found between 42 patients with venous thromboembolism and 42 healthy controls, but male patients manifested a tendency toward higher homocy steine concentrations than male controls.
New England Journal of MedicineHyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
74 Citations1996Marco Cattaneo, Ida Martinelli +1 more
High plasma homocysteine levels are a risk factor for deep-vein thrombosis in the general population and in patients younger than 40 years of age, as compared with controls from the generalpopulation.
Arteriosclerosis Thrombosis and Vascular BiologyPlasma Homocysteine Levels in Patients With Deep Venous Thrombosis
71 Citations1995Tore Amundsen, Per Magne Ueland +1 more
No significant difference in plasmahomocysteine levels between the young adults with deep venous thrombosis and control subjects indicates that hyperhomocysteinemia is not a frequent cause of DVT.
Clinical GeneticsPopulation variation and genetics of plasma homocyst(e)ine level
63 Citations1992Káro Berg, Manuel R. Malinow +2 more
The H(e) level appeared to be independent of other proven or potential risk factors or protective factors with respect to CHD, and the intraclass correlation coefficient in monozygotic (MZ) twins is a (possibly inflated) estimate of heritability.
Journal of Chromatography AHigh-performance liquid chromatographic method with fluorescence detection for the determination of total homocyst(e)ine in plasma
57 Citations1992Isabella Fermo, Cinzia Arcelloni +3 more
A high-performance liquid chromatographic method for the determination of total plasma homocyst(e)ine [H(e)] after reduction with sodium tetrahydroborate and precolumn derivatization with o-phthaldialdehyde is described.
The Netherlands Journal of MedicineHyperhomocysteinaemia: a role in the accelerated atherogenesis of chronic renal failure?
19 Citations1995Marcel Janssen
Treatment with folic acid, 5 mg daily, significantly lowers homocysteine levels in chronic renal patients, and decreased extrarenal catabolism can contribute to the hyperhomocysteinaemia in this disease state.
BloodThe clinical spectrum of heterozygous protein C deficiency in a large New England kindred
18 Citations1989EG Bovill, K Bauer +3 more
Biochemical Society TransactionsRenal metabolism of homocysteine in vivo
15 Citations1995John T. Brosnan, Beatrice Hall +3 more